Mario Torrero pharmacovigilance department of the MoH said that the international alert indicates that such products contain the hormone ethinyl estradiol and etenogestrel components related to the formation of clots and thrombi.
“In Panama pharmacies have registered two products with featuring the vaginal ring device. It should be noted that the national pharmacovigilance center has received no reports of suspected adverse reaction or thrombosis related to these products “, said Torrero.
The department recommended that patients using these devices or those intending to use contraception, consult with medical specialists, about risk factors like age and cardiovascular disease
“Basically they are advised to take appropriate precautions if they have risk factors that increase the likelihood of clots forming” said Torrero.
He added that so far he has not been given orders to withdraw products from the market.